

Initiated by Pfizer China, IQVIA has carried out survey so as to better understand the status quo of "patient-centric" projects in pharmaceutical industry of China. This report, titled as Report on Post-approval stage Projects under the Concept of Patient-centricity in Chinese Pharmaceutical Industry(2021), presents a general overview of all stakeholders' current thinking on patient-centricity and their practical experience based on in-depth interviews with major players in the pharmaceutical industry (foreign companies and domestic ones), academia/associations, foundations, patient communities and healthcare providers along with IQVIA's previous project experience. Addressing the present situation and/or advices for the post-approval stage industry growing, this report aims to provide a visionary insight for the continuous improvement and practice of patient centricity in Chinese pharmaceutical industry. Key information and conclusions are listed here for quick reference by industry experts and peers.